A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

• Status: Completed
• Trial end date: 2020-11-15
• Target enrollment: 0
• Participant gender: All

Summary

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to determine if the drops decrease inflammation and pain inside the eye and are safe after cataract surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: iDrop, Inc.
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate

Criteria

Inclusion Criteria:

• Patients undergoing traditional cataract surgery.

Exclusion Criteria:

• Patients with unusual ocular conditions.